S&P Maintains Avoid on Merck

Plus: Analysts' opinions on AT&T and Marsh & McLennan. Plus more

Merck (MRK ): Reiterates 2 STARS (avoid)

To continue reading this article you must be a Bloomberg Professional Service Subscriber.